Nanosphere: Must Be More Good News

Nanosphere (NSPH) issued this press release today (02011.12.27): Nanosphere Receives FDA Clearance of Gram-Positive Blood Culture Test for Staphylococcus. Today, NSPH closed at $1.53, up 20.5% for the day. NSPH hit an intra-day high of $1.70. Volume was 1.1 million vs. 0.3 million. 52-week range: $0.89 - $5.54

"With this clearance we continue expansion of our product offering, enabling microbiologists to replace century-old methods with rapid, accurate molecular diagnostic tests," said CEO Bill Moffitt.

Rewind about a week...

On 02011.12.19, Nanosphere issused this press release: Nanosphere Obtains CE Mark for Gram-Positive Blood Culture Test. After announcing this news, NSPH spiked from a close of $1.25 on 02011.12.20 to an intra-day high of $1.55 before closing at $1.38. NSPH closed at $1.30 on 02011.2.21 and $1.27 on 02011.12.22 (the last of of trading since today's [02011.12.27] news).

"With the BC-GP test, clinicians treating patients suspected of deadly infections now have a first-of-its-kind diagnostic tool for detecting a broad array of disease-causing bacteria while simultaneously determining antibiotic resistance within the critical timeframe for making and adjusting initial treatment decisions," said Bill Athenson, Nanosphere's Vice President of International Sales and Marketing.

If only a research firm having a significant following would issue a 'Buy' rating on NSPH.